News & Analysis as of

Biden Administration Disney

Robins Kaplan LLP

Google Allows Some Apps to Use Their Own Payment Systems in Effort to Quell Antitrust Furor

Robins Kaplan LLP on

Under growing antitrust scrutiny, Google announced on Wednesday that it would let some apps “offer their own billing system within the Google Play store as part of a pilot program.” That move, affecting Spotify, among others,...more

Robins Kaplan LLP

Financial Daily Dose 3.18.2021 | Top Story: Fed Commits to Near-Zero Rates Despite Improving Economy

Robins Kaplan LLP on

The latest and greatest from Fed Chair Powell as the Fed’s March Open Markets Committee meeting wrapped yesterday, including a markets-pleasing assurance that better-than-expected economic growth wasn’t enough to push the...more

Robins Kaplan LLP

Financial Daily Dose 3.10.2021 | Top Story: Tech Stocks Rebound, Lifting Tesla and Bitcoin

Robins Kaplan LLP on

Tech stocks roared back on Tuesday just a day after the Nasdaq hit correction territory, as “buy-the-dip” won out and led to a nearly-4% jump for the tech-heavy index ...more

Robins Kaplan LLP

Financial Daily Dose 2.22.2021 | Top Story: Boeing Grounds Some 777 Models After Engine Explosion on United Flight

Robins Kaplan LLP on

Boeing needs another aircraft problem like a hole in the head, but that’s just what it got after a right-engine explosion on one of its 777-200 models that had just left Denver en route to Hawaii. ...more

Robins Kaplan LLP

Financial Daily Dose 2.12.2021 | Top story: Bumble Booms in Public Markets Debut

Robins Kaplan LLP on

Bumble hit markets on Thursday with considerable buzz, and markets validated that love, with company shares opening a mind-boggling $33 above its already-increased offering price. ...more

Robins Kaplan LLP

Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology

Robins Kaplan LLP on

Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide